COPD: Pathogenesis and Clinical Features
Factors Affecting the Risk of Infection
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Pneumonia III: Complications and Assessment
Immunodeficiency Diseases
Pneumonia II: Pathophysiology
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 8, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Omnia El-Badawy1, Nahla M Elsherbiny1, Doaa Abdeltawab2
1Department of Medical Microbiology and Immunology, Faculty of Medicine, 68796Assiut University, Assiut, Egypt.
Comorbid COVID-19 patients show decreased T-cells and regulatory T-cells (Tregs), with lower Interleukin-10 (IL-10) levels. These immune changes may predict disease severity in patients with comorbidities.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: